Literature DB >> 33927498

The Use of Tibial Autogenous Cancellous Bone for Late Secondary Alveolar Bone Grafting in Cleft Patients: A Prospective Study.

Nandagopal Vura1, Rajasekhar Gaddipati1, Sudhir Ramisetty1, Sai Kumar Thumu1, Lakpathi Bhukya1.   

Abstract

OBJECTIVES: To evaluate the management of alveolar cleft defects with proximal tibia bone grafts by late secondary alveolar bone grafting.
MATERIALS AND METHODS: Fifteen patients were studied, nine males and six females within age range of 21-32 years. All the patients were treated with cancellous portion of the proximal tibial bone graft, harvested through the medial approach.
RESULTS: Intraoperatively, sufficient amount of bone was harvested which ranged from 19 to 24 ccs (mean 20.7 ccs). In two patients, moderate bleeding had occurred, whereas in remaining patients, mild bleeding was observed. Operative time ranged between 1.25 and 1.50 h (mean 1.36 h). Infection was reported in one patient (7%), which resolved by the end of one and a half months. Complete elimination of the oronasal fistula was achieved in all cases. Neurosensory disturbance (parasthesia) at the donor site was observed in two patients (13%) from the first postoperative week and subsided within 8 months. Gait disturbance was not reported in any of the cases. However, in two patients (13%), intermittent pain during daily activities remained for more than 2 months, which completely resolved by the end of the third month.
CONCLUSION: Tibial graft is a reliable donor site option for grafting in cleft alveolus for which the advantage being minimal donor site morbidity. The resorption rate of the graft is also minimal in the present study. © The Association of Oral and Maxillofacial Surgeons of India 2020.

Entities:  

Keywords:  Alveolar clefts; Bone grafting; Late secondary alveolar bone grafting; Tibial bone graft

Year:  2020        PMID: 33927498      PMCID: PMC8041926          DOI: 10.1007/s12663-020-01350-x

Source DB:  PubMed          Journal:  J Maxillofac Oral Surg        ISSN: 0972-8270


  24 in total

1.  Techniques for harvesting autogenous bone graft of the lower extremity.

Authors:  R W Mendicino; E Leonheart; P Shromoff
Journal:  J Foot Ankle Surg       Date:  1996 Sep-Oct       Impact factor: 1.286

2.  Pelvic instability: a consequence of removing iliac bone for grafting.

Authors:  M B Coventry; E M Tapper
Journal:  J Bone Joint Surg Am       Date:  1972-01       Impact factor: 5.284

3.  Elimination of the residual alveolar cleft by secondary bone grafting and subsequent orthodontic treatment.

Authors:  O Bergland; G Semb; F E Abyholm
Journal:  Cleft Palate J       Date:  1986-07

4.  Secondary bone grafting of alveolar clefts. A surgical/orthodontic treatment enabling a non-prosthodontic rehabilitation in cleft lip and palate patients.

Authors:  F E Abyholm; O Bergland; G Semb
Journal:  Scand J Plast Reconstr Surg       Date:  1981

5.  Lumbar hernia at an iliac bone graft donor site. A case report.

Authors:  M Lotem; P Maor; H Haimoff; Y Woloch
Journal:  Clin Orthop Relat Res       Date:  1971-10       Impact factor: 4.176

6.  Bone grafting from the proximal tibia.

Authors:  V Alt; A Nawab; D Seligson
Journal:  J Trauma       Date:  1999-09

7.  Fracture of the anterior superior iliac spine following anterior cervical fusion using iliac crest. Case report.

Authors:  A F Reynolds; P T Turner; J D Loeser
Journal:  J Neurosurg       Date:  1978-05       Impact factor: 5.115

8.  Harvesting of autogenous cancellous bone graft from the proximal tibial metaphysis. A review of 230 cases.

Authors:  R M O'Keeffe; B L Riemer; S L Butterfield
Journal:  J Orthop Trauma       Date:  1991       Impact factor: 2.512

9.  Early results of secondary bone grafts in 106 alveolar clefts.

Authors:  H D Hall; J C Posnick
Journal:  J Oral Maxillofac Surg       Date:  1983-05       Impact factor: 1.895

10.  Fracture and herniation of bowel at bone graft donor site in the iliac crest.

Authors:  C S Ubhi; D L Morris
Journal:  Injury       Date:  1984-11       Impact factor: 2.586

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.